Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

被引:0
作者
Ole Haagen Nielsen
Edward V Loftus Jr
Tine Jess
机构
[1] Medical Section,Department of Gastroenterology
[2] Herlev Hospital,Division of Gastroenterology & Hepatology
[3] University of Copenhagen,Department of Epidemiology Research
[4] Mayo Clinic,undefined
[5] Statens Serum Institute,undefined
[6] National Health Surveillance and Research,undefined
来源
BMC Medicine | / 11卷
关键词
Biologics; Crohn’s disease; IBD; Lactation; Pregnancy; Ulcerative colitis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 471 条
  • [1] Cornish J(2007)A meta-analysis on the influence of inflammatory bowel disease on pregnancy Gut 56 830-837
  • [2] Tan E(2007)Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case–control study J Gastroenterol Hepatol 22 542-549
  • [3] Teare J(1998)Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries Am J Gastroenterol 93 2426-2430
  • [4] Teoh TG(1983)Pregnancy in ulcerative colitis Scand J Gastroenterol 18 735-742
  • [5] Rai R(1984)Pregnancy in Crohn’s disease Scand J Gastroenterol 19 724-732
  • [6] Clark SK(2008)Inflammatory bowel disease in pregnancy BMJ 337 a427-311
  • [7] Tekkis PP(2006)American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy Gastroenterology 131 283-28
  • [8] Bortoli A(2011)Use of biological molecules in the treatment of inflammatory bowel disease J Intern Med 270 15-131
  • [9] Saibeni S(2012)IBD: Can TNF inhibitors be administered during the third trimester? Nat Rev Gastroenterol Hepatol 10 130-773
  • [10] Tatarella M(2011)Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease Curr Pharm Biotechnol 12 765-321